Unkategorisiert 2 Min Laborie Publishes 2025 Sustainability Report Global medical technology company Laborie has published its 2025 Sustainability... Geschrieben von Laborie
Unkategorisiert 4 Min Laborie Announces First Procedures in ENDURE 1 Study with the Optilume® Ureteric Drug-Coated Balloon Landmark procedures launch the ENDURE 1 clinical study evaluating Optilume’s... Geschrieben von Laborie
Unkategorisiert 3 Min Laborie Appoints Chris Smith as Chief Executive Officer Laborie Medical Technologies Corp., a global leader in medical technology,... Geschrieben von Laborie
Unkategorisiert | Urologie und Urogynäkologie 3 Min Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association Laborie Medical Technologies Corp (Laborie), announced today that the American... Geschrieben von Laborie
Unkategorisiert 4 Min Laborie Medical Technologies Invests in Medical Technology Start-Up Bright Uro Laborie Medical Technologies announced a strategic equity investment in Bright... Geschrieben von Laborie
Unkategorisiert | Urologie und Urogynäkologie 5 Min Laborie Medical Technologies Acquires Urotronic Urotronic joins Laborie as part of a long-term growth strategy... Geschrieben von Laborie
Unkategorisiert | Urologie und Urogynäkologie 5 Min Laborie Medical Technologies Announces Agreement to Acquire Urotronic for up to $600 Million Acquisition expands urology portfolio and demonstrates Laborie’s commitment to providing... Geschrieben von Laborie
Unkategorisiert 4 Min Laborie Transitions Urology and Gastroenterology Sales Model in Australia Geschrieben von Laborie
Unkategorisiert 6 Min Laborie’s Optilume® Technology Receives UK NICE Guideline Recommendations Geschrieben von mburgers